Related Experiment Video
Updated: May 28, 2026
12:49
Mutagenesis and Analysis of Genetic Mutations in the GC-rich KISS1 Receptor Sequence Identified in Humans with Reproductive Disorders
Published on: September 4, 2011
Gitelman syndrome: novel mutation and long-term follow-up
Aditi Sinha1, Petr Lněnička, Biswanath Basu
1Division of Pediatric Nephrology, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, 110029, India. aditisinha4@rediffmail.com
Clinical and Experimental Nephrology
|October 4, 2011
Summary
Gitelman syndrome, a kidney disorder, can cause fatigue and muscle weakness. A novel mutation in the SLC12A3 gene was identified, and treatment with supplements and spironolactone improved symptoms.
Area of Science:
- Nephrology
- Medical Genetics
Background:
- Gitelman syndrome is a rare genetic disorder affecting kidney salt reabsorption.
- It typically presents with electrolyte imbalances like hypokalemia and hypomagnesemia.
Observation:
- A patient presented with chronic fatigue, paresthesias, and muscle weakness since early childhood.
- Clinical findings included hypokalemia, hypomagnesemia, and excessive urinary magnesium loss.
Findings:
- Genetic analysis identified a novel homozygous mutation in the SLC12A3 gene.
- This mutation likely underlies the observed Gitelman syndrome phenotype.
Implications:
- Early diagnosis and management of Gitelman syndrome are crucial for patient well-being.
- Supplementation and medication can effectively manage symptoms and support normal development.
